TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
PROK

ProKidney Corp.

Healthcare · Biotechnology

1.60$ +1.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PROK
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
78.7% 33.4% 67.7% 97.4% 89.0% 89.8% 83.6%
77.7% 27.4% 51.0% 94.6% 14.4% 22.5% 32.3%
77.7% 27.4% 51.0% 94.6% 86.3% 81.2% 80.5%
– – – – 0.3% 0.6% 0.3%
17.0% 62.7% 31.3% 2.1% – – –
– 3.8% 1.1% – – – –
4.4% 0.0% 1.1% 0.0% – – –
19.0% 40.9% 33.2% 2.5% 6.9% 8.9% 10.4%
13.8% 32.9% 30.6% 2.1% 6.0% 8.2% 9.2%
0.5% 1.3% 0.7% 0.1% 0.2% 0.2% 0.3%
2.4% 4.7% 7.0% 0.6% 1.2% 0.8% 0.3%
81.0% 59.1% 66.8% -211.7% -262.4% -225.6% -301.3%
-406.1% -636.9% -400.8% -213.2% -271.0% -272.3% -378.4%
400.5% 1,116.8% 79.1% 11.9% 14.7% 22.2% 39.9%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?